Skip to main content

Advertisement

Log in

Meprobamate–Tranquilizer or Anxiolytic? A Historical Perspective

  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

Meprobamate was the first successful anti-anxiety drug of the modern era. On the 50th anniversary of its introduction, the authors trace the development of its synthesis, marketing and runaway success to understand the scientific and socio-political factors that may have shaped its use in clinical psychiatry. The relationship of this drug to the earlier development of chlorpromazine is explored to clarify the imperatives of drug classification in modern psychiatry.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ayd FJ: The impact of biological psychiatry. In Discoveries in Biological Psychiatry. Edited by Ayd FJ, Blackwell B. Philadelphia, Lippincott, 1970.

  2. López-Muñoz F, Alamo C, Rubio G, et al: Half a century since the clinical introduction of chlorpromazine and the birth of modern psychopharmacology. Progress in Neuro-Psychopharmacology & Biological Psychiatry 28:205–208, 2004.

    Google Scholar 

  3. de Ropp RS: Drugs and the Mind. New York, St. Martinapos;s Press, 1957.

    Google Scholar 

  4. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistics Manual, Mental Disorders (DSM I). Washington DC, APA, 1952.

  5. Caldwell AE: Origins of Psychopharmacology—From CPZ to LSD. Springfield, Charles C Thomas, 1970.

  6. Goldman D: Treatment of psychotic states with chlorpromazine. Journal of American Medical Association 157:1274–1278, 1955.

    CAS  Google Scholar 

  7. Alamo C, López-Muñoz F, Echániz T, et al: Farmacos ansioliticos, sedantes e hipnoticos. In Historia de la Neuropsicofarmacología. Una nueva aportación a la terapéutica farmacológica de los trastornos del Sistema Nervioso Central. Edited by López-Muñoz F, Alamo C. Madrid, Ediciones Eurobook S.L., 1998.

  8. Healy D: The Creation of Psychopharmacology. Cambridge, Harvard University Press, 2002.

    Google Scholar 

  9. Johns MW: Self-poisoning with barbiturates in England and Wales during 1959–1974. British Medical Journal 1:1128–1130, 1977.

    Article  CAS  PubMed  Google Scholar 

  10. Sharpless SK: Hypnotics and sedatives. In The Pharmacological Basis of Therapeutics, 4th ed. Edited by Goodman LS, Gilman A. New York, The Macmillan Company, 1970.

  11. de Ropp RS: Drugs and the Mind. New York, St. Martinapos;s Press, 1957.

  12. Herman M, Nagler SH: Psychoses due to amphetamine. Journal of Nervous and Mental Disease 120:268, 1954.

    Google Scholar 

  13. Leake CD: The Long Road for a Drug from Idea to Use. In Discoveries in Biological Psychiatry. Edited by Ayd FJ, Blackwell B. Philadelphia, Lippincott, 1970.

  14. Berger FM, Bradley W: The pharmacological properties of a alpha, beta-dihydroxy-gama-(2-methylphenoxy)-propane (Myanesisn). British Journal of Pharmacology 1:265–272, 1946.

    CAS  Google Scholar 

  15. Mallison FB: A new synthetic curarising agent in anaesthesia. Lancet i:98–100, 1947.

  16. Pichot P: History of the treatment of anxiety. In Handbook of Anxiety, vol. 4: The Treatment of Anxiety. Edited by Noyes R, Roth M, Burrows GD. Amsterdam, Elsevier Science Publishers, 1990.

  17. Berger FM: Mode of action of Myanesin. British Journal of Pharmacology 2:241, 1947.

    Google Scholar 

  18. Ludwig BJ, Potterfield JR: The pharmacology of propanediol carbamates. Advances in Pharmacology and Chemotherapy 9:173–240, 1971.

    CAS  PubMed  Google Scholar 

  19. Berger FM: The anticonvulsant activity of carbamate esters of certain of 2, 2-disubstituted-l, 3-propanediols. Journal of Pharmacological Therapy 104:229, 1952.

    Google Scholar 

  20. Ludwig BJ, Piech E: Some anticonvulsant agents derived from 1, 3-propanediol. Journal of American Chemical Society 73:5779–5781, 1951.

    CAS  Google Scholar 

  21. Berger FM: Anxiety and the discovery of the tranquillizers. In Discoveries in Biological Psychiatry. Edited by Ayd FJ, Blackwell B. Baltimore, Ayd Medical Communications, 1984.

  22. Shorter E: A History of Psychiatry: From the Era of the Asylum to the Age of Prozac. New York, John Wiley & Son, 1997.

    Google Scholar 

  23. Farrar GE: Milestones in clinical pharmacology. Psychopharmacology of depression and anxiety. Clinical Therapeutics 13:521–524, 1991.

    Google Scholar 

  24. Berger FM: Meprobamate and other agents used in mental disorders. Annals of NY Academy of Sciences 67:671–894, 1957.

    Google Scholar 

  25. Greenblatt DJ, Shader RI: Meprobamate: a study of irrational drug use. American Journal of Psychiatry 127:1297–1303, 1971.

    CAS  PubMed  Google Scholar 

  26. Hollister LE: The pre-benzodiazepine era. Journal of Psychoactive Drugs 15:9–13, 1983.

    CAS  PubMed  Google Scholar 

  27. Selling LS, Orlando PH: Clinical study of a new tranquilizing drug. Journal of American Medical Association 157:1594–1596, 1957.

    Google Scholar 

  28. Borrus JC: Study of effect of Miltown on psychiatric states. Journal of American Medical Association 157:1596–1598, 1957.

    Google Scholar 

  29. Lasagna L: A study of hypnotic drugs in chronic disease. Journal of Chronic Disease 3:122–133, 1956.

    CAS  Google Scholar 

  30. Katz EL: Sedatives and tranquilizers. New England Journal of Medicine 286:757–760, 1972.

    Article  CAS  PubMed  Google Scholar 

  31. Fabing HD: Frenquel a blocking agent against experimental LSD-25 and mescaline psychosis. Preliminary note on its clinical application. Neurology 5:319, 1955.

    Google Scholar 

  32. Wittenborn JR: The Clinical Psychopharmacology of Anxiety. Springfield, Charles C Thomas, 1966.

  33. Smith ME, Chassan JB: Comparisons of diazepam, chlorpromazine and trifluoperazine in a double-blind clinical investigation. Journal of Neuropsychiatry 5:593–600, 1964.

    CAS  PubMed  Google Scholar 

  34. Brougher JC: The treatment of emotional disorders in obstetrics and gynecology with thioridazine. Quarterly Review of Surgery, Obstetrics and Gynecology 17:44–47, 1960.

    CAS  PubMed  Google Scholar 

  35. Deniker P: Introduction of Neuroleptic Chemotherapy into Psychiatry. In Discoveries in Biological Psychiatry. Edited by Ayd FJ, Blackwell B. Philadelphia, Lippincot, 1970.

  36. Pennington VM: Use of Miltown with psychotic patients. American Journal of Psychiatry 114:257, 1957.

    Google Scholar 

  37. Laties VG, Weiss B: A critical review of the efficacy of meprobamate in the treatment of anxiety. Journal of Chronic Disease 7:500–519, 1958.

    Article  CAS  Google Scholar 

  38. World Health Organization: Research in Psychopharmacology. Technology Report Service 371:5, 1967.

  39. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistics Manual, Mental Disorders (DSM II). Washington DC, APA, 1968.

  40. Elkes J: Psychopharmacology: On Beginning in a New Science. In Discoveries in Biological Psychiatry. Edited by Ayd FJ, Blackwell B. Philadelphia, Lippincott, 1970.

  41. López-Muñoz F, Alamo C, Cuenca E: El nacimiento de la era ansiolitica: Frank M. Berger y el desarrollo del meprobamato. JANO (Psiquiatrıa y Humanidades) I(2):13–14, 1999.

  42. Cohen IM: The benzodiazepines. In Discoveries in Biological Psychiatry. Edited by Ayd FJ, Blackwell B. Baltimore, Ayd Medical Communications, 1984.

  43. Eison MS, Eison AS: Buspirone as a midbrain modulator: anxiolitics unrelated to traditional benzodiazepine mechanism. Drug Development and Research 4:109–119, 1984.

    CAS  Google Scholar 

  44. Blackwell B: The Process of Discovery. In Discoveries in Biological Psychiatry. Edited by Ayd FJ, Blackwell B. Philadelphia, Lippincott, 1970.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dilip Ramchandani M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramchandani, D., López-Muñoz, F. & Alamo, C. Meprobamate–Tranquilizer or Anxiolytic? A Historical Perspective. Psychiatr Q 77, 43–53 (2006). https://doi.org/10.1007/s11126-006-7960-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11126-006-7960-z

Key Words

Navigation